White Paper

Four Reasons For The Rise In Blister Packaging

Source: Ropack Pharma Solutions

By Yves Massicotte, Ropack, Inc.

blister packaging iStock-1129906441

Blister packaging, not long ago considered a less significant segment of the North American pharmaceutical packaging industry, is now outpacing most other industry segments. Blister packaging reduces costs for OTC and Rx drug manufacturing significantly. Blister packaging also offers tamper proof solutions in a highly competitive market. The pharmaceutical manufacturing industry has witnessed a significant increase in the number of drug approvals by the FDA over the past few years leading to several packaging innovations.

Following are the four factors that are driving blister to the forefront of pharmaceutical packaging, and at an even faster rate than its current growth.

VIEW THE WHITE PAPER!

Get unlimited access to:

Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue. X

Enter your credentials below to log in. Not yet a member of Clinical Leader? Subscribe today.

Subscribe to Clinical Leader X

Please enter your email address and create a password to access the full content, Or log in to your account to continue.

or

Subscribe to Clinical Leader